|
⚲
|
| Keyboard |
| Laufer Ron
✚
|
|
|---|---|
| CIK # | 0001645130 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001645130] | |
| 4 | [0001645130] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Laufer Ron | |
| Catabasis Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catabasis Pharmaceuticals Inc CATB
Common Stock
|
2015-06-30 | Buy | 223,439 | $12.00 | 2,681,268 |
|
Catabasis Pharmaceuticals Inc CATB
Common Stock
|
2015-06-30 | Conversion | 1,079,115 | ||
|
Catabasis Pharmaceuticals Inc CATB
Common Stock
|
2015-06-30 | Conversion | 330,098 | ||
|
Catabasis Pharmaceuticals Inc CATB
Series B Preferred Stock · derivative
|
2015-06-30 | Conversion | 4,241,780 | $0.00 | |
|
Catabasis Pharmaceuticals Inc CATB
Series A Preferred Stock · derivative
|
2015-06-30 | Conversion | 13,866,666 | $0.00 | |
|
Catabasis Pharmaceuticals Inc CATB
Stock Option (right to buy) · derivative
|
2015-06-30 | Grant | 11,094 | $0.00 |